CVB homepage

Ronen Rubinshtein, MD, FACC, FESC, director, heart institute, Edith Wolfson Medical Center, in Holon, Israel, president elect for the Society of Cardiovascular Computed Tomography (SCCT), and chairman of the SCCT 2026 annual scientific meeting, explains plaque imaging, AI and structural heart disease are the spotlight at the meeting.

Coronary plaque imaging is an area many experts believe is driving a shift toward earlier detection and prevention of heart disease.

A figure from the new SCCT FFR-CT consensus document to help explain how the technology works to assess hemodynamic flow using CT imaging.

FFR-CT literature has reached a state of maturity where experts can comfortably start to provide guidelines to the wider community. 

Robert Hawkins, MD, MSC, assistant professor of cardiac surgery, University of Michigan, discusses the growing trends of surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR) and how to best risk assess these patients using a new STS risk calculator.

Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business.

Former ACC president William Parmley, 1936-2026.

Parmley is most noted for his research on the harmful effects of secondhand smoke, hemodynamics and new therapies for heart failure. 

Physician warning

This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected. 

ultrasound pacemaker

The engineers behind this new device envision a future where patients wear a single postage stamp-sized sticker that images and stimulates the heart. 

Innovation at work

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx